GlaxoSmithKline Pharmaceuticals Ltd reported an 18% revenue increase to ₹946 crore for Q3 ended December 31, 2024, with a ...
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin.
The healthcare sector, as of 2024, is one of India’s largest employers, employing a total of 7.5 million people. * The demand for Indian healthcare professionals is expected to double nationally and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback